Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T14:22:32.572Z Has data issue: false hasContentIssue false
  • English
  • Français

Control of Nosocomial Acquisition of Vancomycin-Resistant Enterococcus Through Active Surveillance of Hemodialysis Patients

Published online by Cambridge University Press:  02 January 2015

R. Neal Axon ,
John J. Engemann ,
James Butcher ,
Kathy Lockamy  and
Keith S. Kaye
R. Neal Axon
Affiliation:
Department of Medicine, Duke University Medical Center, Durham, North Carolina
John J. Engemann
Affiliation:
Department of Medicine, Duke University Medical Center, Durham, North Carolina Duke Infection Control Outreach Network (DICON), Durham, North Carolina
James Butcher
Affiliation:
Cape Fear Valley Regional Medical Center, Fayetteville, North Carolina
Kathy Lockamy
Affiliation:
Cape Fear Valley Regional Medical Center, Fayetteville, North Carolina
Keith S. Kaye*
Affiliation:
Department of Medicine, Duke University Medical Center, Durham, North Carolina Duke Infection Control Outreach Network (DICON), Durham, North Carolina Cape Fear Valley Regional Medical Center, Fayetteville, North Carolina
*
Department of Medicine, Division of Infectious Diseases and International Health, DUMC 3152, Durham, NC 27710
Get access Rights & Permissions [Opens in a new window]

Abstract

Hemodialysis-dependent patients are an important VRE source. After implementation of active surveillance for VRE targeting hemodialysis patients, the hospital-wide nosocomial VRE rate increased by 41%, but decreased by 41% among non-hemodialysis patients (P = .05). To assess the effectiveness of active surveillance, patients undergoing active surveillance should be analyzed separately from other patients.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 5 , May 2004 , pp. 436 - 438
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992-June 2002, issued August 2002. Am J Infect Control 2002;30:458–475.CrossRefGoogle Scholar
2.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.CrossRefGoogle ScholarPubMed
3.D'Agata, EM, Green, WK, Schulman, G, Li, H, Tang, YW, Schaffner, W. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis 2001;32:23–29.CrossRefGoogle ScholarPubMed
4.Tokars, JI, Frank, M, Alter, MJ, Arduino, MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002;15:162–171.CrossRefGoogle ScholarPubMed
5.Montecalvo, MA, Jarvis, WR, Uman, J, et al.Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269–272.CrossRefGoogle Scholar
6.Bonten, MJ, Hayden, MK, Nathan, C, et al.Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996;348:1615–1619.CrossRefGoogle ScholarPubMed
7.Calfee, DP, Giannetta, ET, Durbin, IJ, Germanson, TP, Farr, BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003;37:326–332.CrossRefGoogle ScholarPubMed
8.Recommendations for preventing the spread of vancomycin resistance. MMWR 1995;44(RR-12):1–13.Google Scholar
9.Byers, KE, Anglim, AM, Anneski, CJ, et al.A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140–147.CrossRefGoogle ScholarPubMed
10.Shaikh, ZH, Osting, CA, Hanna, HA, Arbuckle, RB, Tarr, JJ, Raad, II. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect 2002;51:52–58.CrossRefGoogle Scholar